Production (Stage)
Spectral Medical Inc.
EDTXF
$0.614
$0.0040.66%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -13.50% | 25.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.50% | 25.18% | |||
| Cost of Revenue | -4.96% | -18.39% | |||
| Gross Profit | -19.81% | 106.55% | |||
| SG&A Expenses | 34.29% | -7.85% | |||
| Depreciation & Amortization | -33.33% | -8.53% | |||
| Other Operating Expenses | 43.71% | -76.07% | |||
| Total Operating Expenses | 29.71% | -12.04% | |||
| Operating Income | -40.85% | 18.30% | |||
| Income Before Tax | -489.22% | 130.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -489.22% | 130.79% | |||
| Earnings from Discontinued Operations | 27.59% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -489.81% | 130.75% | |||
| EBIT | -40.85% | 18.30% | |||
| EBITDA | -41.42% | 18.38% | |||
| EPS Basic | -489.87% | 130.38% | |||
| Normalized Basic EPS | -486.00% | 130.67% | |||
| EPS Diluted | -489.87% | 130.38% | |||
| Normalized Diluted EPS | -486.00% | 130.67% | |||
| Average Basic Shares Outstanding | 0.44% | 0.64% | |||
| Average Diluted Shares Outstanding | 0.44% | 0.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||